cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ani Pharmaceuticals Inc
9 own
19 watching
Current Price
$58.64
$-0.05
(-0.09%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,230.82M
52-Week High
52-Week High
70.81000
52-Week Low
52-Week Low
52.5
Average Volume
Average Volume
0.08M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
32515
iconMarket Capitalization1,230.82M
icon52-Week High70.81000
icon52-Week Low52.5
iconAverage Volume0.08M
iconDividend Yield--
iconP/E Ratio32515
What does the Ani Pharmaceuticals Inc do?
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. It focuses on producing controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. The company offers Erythromycin Ethylsuccinate to treat infections; Esterified Estrogen with Methyltestosterone for treating vasomotor symptoms of menopause; Etodolac to treat pain caused by osteoarthritis, rheumatoid arthritis, and other conditions; Fenofibrate for treating hypercholesterolemia; Flecainide to treat arrhythmia; Fluvoxamine for treating obsessive-compulsive and social anxiety disorders; and Hydrocortisone Enema and Cortenema to treat ulcerative colitis. It also provides Hydrocortisone Rectal Cream to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; Lithium Carbonate ER and Lithobid for bipolar disorder; Mesalamine Enema to treat distal ulcerative colitis, proctosigmoiditis, or proctitis; Methazolamide to treat ocular conditions; and Metoclopramide and Reglan to treat gastroesophageal reflux. In addition, the company offers Nilutamide to treat metastatic prostate cancer; Nimodipine that reduces the ischemic deficits in patients with subarachnoid hemorrhage; Opium Tincture to treat diarrhea; Oxycodone capsules and oral solution for pain; Propafenone to treat arrhythmia; Propranolol ER and Inderal LA for managing hypertension in patients with angina pectoris; and Vancomycin and Vancocin for use in treating C. difficile-associated diarrhea and enterocolitis. Further, it provides contract manufacturing services for other pharmaceutical companies. The company markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. is headquartered in Baudette, Minnesota.
Read More
How much money does Ani Pharmaceuticals Inc make?
News & Events about Ani Pharmaceuticals Inc.
Ticker Report
1 year ago
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP Get Rating) COO Muthusamy Shanmugam sold 14,657 shares of the firms stock in a transaction on Tuesday, June 20th. The stock was sold at an average price of $51.93, for a total transaction of $761,138.01. Following the transaction, the chief ...
Ticker Report
1 year ago
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP Get Rating) COO Muthusamy Shanmugam sold 13,500 shares of the stock in a transaction that occurred on Thursday, June 22nd. The stock was sold at an average price of $51.38, for a total transaction of $693,630.00. Following the transaction, the chief ...
Ticker Report
2years ago
Equities research analysts forecast that ANI Pharmaceuticals, Inc. (NASDAQ:ANIP Get Rating) will post earnings of $0.04 per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for ANI Pharmaceuticals earnings, with the highest...
Frequently Asked Questions
Frequently Asked Questions
What is Ani Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Ani Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Ani Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Ani Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Ani Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Ani Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Ani Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Ani Pharmaceuticals Inc?
plus_minus_icon
What percentage is Ani Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Ani Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$58.64
$-0.05
(-0.09%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
NovoCure Limited
NovoCure Limited
$26.33
$-0.69 (-2.55 %)
Nevro Corp
Nevro Corp
$5.16
$0.08 (1.57 %)
Xencor Inc
Xencor Inc
$19.65
$-0.81 (-3.96 %)
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc
$5.52
$-0.02 (-0.36 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
NovoCure Limited
NovoCure Limited
$26.33
$-0.69 (-2.55 %)
Nevro Corp
Nevro Corp
$5.16
$0.08 (1.57 %)
Xencor Inc
Xencor Inc
$19.65
$-0.81 (-3.96 %)
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc
$5.52
$-0.02 (-0.36 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00